Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nonsynonymous single nucleotide polymorphisms in candidate genes P2RY1, P2RY12 and CYP2C19 for clopidogrel efficacy in cats.

Animal genetics - 1 Aug 2018

Ueda Yu, Li Ronald Hak Long, Tablin Fern, Ontiveros Eric S, Stern Joshua A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cats
Share to Clopidogrel
Share to Cytochrome P-450 CYP2C19
Share to Drug Resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Receptors, Purinergic P2Y12

Share to Ticlopidine

Source

Identifiers

PMID: 29774574
DOI: 10.1111/age.12666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nonsynonymous single nucleotide polymorphisms in candidate genes P2RY1, P2RY12 and CYP2C19 for clopidogrel efficacy in cats.PMID 29774574Read ↗

A genetic polymorphism in P2RY1 impacts response to clopidogrel in cats with hypertrophic cardiomyopathy.Semantic proximity Read ↗

Genetic Determinants of P2Y12 Inhibitors and Clinical Implications.Semantic proximity Read ↗

Association between P2RY12 gene polymorphisms and adverse clinical events in coronary artery disease patients treated with clopidogrel: A systematic review and meta-analysis.Semantic proximity Read ↗

Clinical relevant polymorphisms affecting clopidogrel pharmacokinetics and pharmacodynamics: Insights from the Puerto Rico Newborn Screening ProgramSemantic proximity Read ↗

Development of a multiplex and cost-effective genotype test toward more personalized medicine for the antiplatelet drug clopidogrel.Semantic proximity Read ↗

SNP genetic polymorphisms of MDR-1, CYP1A2 and CYPB11 genes in four canine breeds upon toxicological evaluation.Semantic proximity Read ↗

Correlation Between SNPs in Candidate Genes and VerifyNow-Detected Platelet Responsiveness to Aspirin and Clopidogrel Treatment.Semantic proximity Read ↗

Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population.Semantic proximity Read ↗

Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study.Semantic proximity Read ↗

Clinical Relevant Polymorphisms Affecting Clopidogrel Pharmacokinetics and Pharmacodynamics: Insights from the Puerto Rico Newborn Screening Program.Semantic proximity Read ↗

PON1 Q192R and clopidogrel: a case of the winner's curse or inadequate replication?Semantic proximity Read ↗

Polymorphisms of genes related to phase II metabolism and resistance to clopidogrel.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.